This resolution aims to acknowledge the profound challenges faced by children and families affected by neuroblastoma , a prevalent and often aggressive childhood cancer. It also seeks to commend the tireless work of clinicians and researchers who are dedicated to understanding and combating this disease. Neuroblastoma is the most common cancer in infants and a leading cause of pediatric cancer deaths, with many cases diagnosed before age five. High-risk forms of the disease are particularly difficult to treat, often requiring intensive therapies and leading to significant lifelong health complications for survivors. The resolution underscores the critical need for increased awareness, research funding, and therapeutic development, as children with high-risk or relapsed neuroblastoma still face limited effective treatment options and a high risk of relapse. Therefore, it expresses support for designating September 3, 2026 , as "Neuroblastoma Awareness Day" to foster greater public understanding and support for those impacted by the disease and the scientific community working towards cures.